General Biotechnologies (2026) produces oral GLP-1s, insulin and peptides at a fraction of current costs.
Instead of using chemistry to manufacture drugs, edible microbes are genetically engineered to synthesise bespoke pharmaceutical molecules - turning ordinary cells into fully programmable biological factories. A 20g powder taken once daily with food, can deliver the oral dose of GLP-1s peptides for absorption via the gastrointestinal tract - eliminating the need for injections.
Instead of using chemistry to manufacture drugs, edible microbes are genetically engineered to synthesise bespoke pharmaceutical molecules - turning ordinary cells into fully programmable biological factories. A 20g powder taken once daily with food, can deliver the oral dose of GLP-1s peptides for absorption via the gastrointestinal tract - eliminating the need for injections.